Home › Follicular Lymphoma
Pag-aaral pangklinika para sa Follicular Lymphoma na nagre-recruit sa U.S.
108 pag-aaral para sa Follicular Lymphoma ang nagre-recruit ng mga kalahok sa mga site sa buong Estados Unidos.
Mga lungsod na may pinakamaraming pag-aaral
- New York City, NY24 pag-aaral
- Milwaukee, WI19 pag-aaral
- Houston, TX18 pag-aaral
- Nashville, TN18 pag-aaral
- Boston, MA17 pag-aaral
- Baldwin Park, CA16 pag-aaral
- Seattle, WA16 pag-aaral
- Durham, NC15 pag-aaral
- Columbus, OH14 pag-aaral
- Philadelphia, PA12 pag-aaral
- San Antonio, TX12 pag-aaral
- Salt Lake City, UT12 pag-aaral
- Chicago, IL12 pag-aaral
- Los Angeles, CA11 pag-aaral
- Dallas, TX11 pag-aaral
- Edison, NJ11 pag-aaral
- Washington, DC11 pag-aaral
- Denver, CO11 pag-aaral
- Jacksonville, FL10 pag-aaral
- Rochester, MN10 pag-aaral
- Atlanta, GA10 pag-aaral
- Cincinnati, OH9 pag-aaral
- Portland, OR9 pag-aaral
- New Haven, CT9 pag-aaral
- Cleveland, OH9 pag-aaral
- Pittsburgh, PA8 pag-aaral
- Miami, FL8 pag-aaral
- San Diego, CA8 pag-aaral
- San Francisco, CA7 pag-aaral
- Cedar Rapids, IA7 pag-aaral
- Tampa, FL7 pag-aaral
- Charlotte, NC7 pag-aaral
- Queens, NY7 pag-aaral
- Clifton, NJ7 pag-aaral
- Mountain View, CA7 pag-aaral
- Austin, TX6 pag-aaral
- Winston-Salem, NC6 pag-aaral
- Greenburgh, NY6 pag-aaral
- St. Louis, MO6 pag-aaral
- Lexington, KY5 pag-aaral
Ayos sa estado
- Alabama5 pag-aaral
- Arizona11 pag-aaral
- Arkansas3 pag-aaral
- California37 pag-aaral
- Colorado14 pag-aaral
- Connecticut10 pag-aaral
- Delaware4 pag-aaral
- District of Columbia4 pag-aaral
- Florida25 pag-aaral
- Georgia13 pag-aaral
- Illinois14 pag-aaral
- Indiana7 pag-aaral
- Iowa9 pag-aaral
- Kansas7 pag-aaral
- Kentucky10 pag-aaral
- Louisiana8 pag-aaral
- Maryland9 pag-aaral
- Massachusetts20 pag-aaral
- Michigan12 pag-aaral
- Minnesota18 pag-aaral
- Mississippi3 pag-aaral
- Missouri9 pag-aaral
- Nebraska4 pag-aaral
- New Jersey15 pag-aaral
- New Mexico3 pag-aaral
- New York30 pag-aaral
- North Carolina23 pag-aaral
- Ohio24 pag-aaral
- Oklahoma4 pag-aaral
- Oregon12 pag-aaral
- Pennsylvania17 pag-aaral
- Rhode Island4 pag-aaral
- South Carolina6 pag-aaral
- Tennessee19 pag-aaral
- Texas35 pag-aaral
- Utah12 pag-aaral
- Virginia9 pag-aaral
- Washington20 pag-aaral
- Wisconsin21 pag-aaral
Mga pag-aaral na kamakailan lamang in-update
Opisyal na teksto ng pag-aaral (English)
Rituximab and Zanubrutinib in Patients With Indolent B-cell Lymphomas
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT06350318A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT05006716A Clinical Trial of MK-1045 and Rituximab in People With Follicular Lymphoma (MK-1045-007)
Nagre-recruitPhase 2/3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07634471A Clinical Study of MK-1045 in People With Non-Hodgkin Lymphoma (MK-1045-008)
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07519772Epco, Zanu, Ritux for R/R FL or MZL
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06563596A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT03460977Vaccine Responses in Patient With Multiple Myeloma and Non-Hodgkin Lymphoma After CAR-T Treatment
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Set 23, 2026 · NCT06784167Mosunetuzumab and Polatuzumab Vedotin for the Treatment of Patients With Relapsed or Refractory Grade 1-3a Follicular Lymphoma
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT06453044A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07226843A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07101328A Study of Debio 0123 in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Debio 0123 in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed Glioblastoma
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT05765812A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Patients
Nagre-recruitPhase 3
Edad 18 hanggang 130 · Lahat ng kasarian · Na-update Set 21, 2026 · NCT06549595huCART19-IL18-eDHFR Cells in Relapsed/Refractory Follicular Lymphoma
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 16, 2026 · NCT07343934NEO100 and High-Grade Meningioma
Nagre-recruitPhase 2
Edad 12 pataas · Lahat ng kasarian · Na-update Set 15, 2026 · NCT05023018Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 11, 2026 · NCT06526793Study to Evaluate the Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients With Grade 1 and Grade 2 Advanced GEP-NET
Nagre-recruitPhase 3
Edad 12 hanggang 100 · Lahat ng kasarian · Na-update Set 11, 2026 · NCT06784752A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Different Types of Chemotherapy for Adult Participants With Previously Untreated Follicular Lymphoma
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 11, 2026 · NCT06091254Rituximab (Rtx) + Tafasitamab in Combination With Allogeneic NK Cells for Treatment of Relapsed/Refractory (r/r) B-cell Non-Hodgkin Lymphoma (NHL)
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 9, 2026 · NCT07225439A Phase II Study of Axicabtagene Ciloleucel, an Anti-CD19 Chimeric Antigen Receptor (CAR) Tcell Therapy, in Combination With Radiotherapy (RT) in Relapsed/Refractory Follicular Lymphoma
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 4, 2026 · NCT06043323Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 2, 2026 · NCT06860594A Longitudinal Multi-Center Molecular Biomarker Discovery Registry for Patients With Hematologic Malignancies
Nagre-recruitObservasyonal na pag-aaral
Edad 0 pataas · Lahat ng kasarian · Na-update Set 2, 2026 · NCT07154823Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer
Nagre-recruitPhase 3
Edad 12 pataas · Lahat ng kasarian · Na-update Set 2, 2026 · NCT07215910A Phase I Study to Investigate the Effect of Hepatic Impairment of AZD9550 and AZD6234
Nagre-recruitPhase 1Malugod na tinatanggap ang malusog na boluntaryo
Edad 18 hanggang 85 · Lahat ng kasarian · Na-update Set 1, 2026 · NCT07546760Phase 2 Trial of Obinutuzumab and CC-99282 for Patients With Previously Untreated High Tumor Burden Follicular Lymphoma
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 31, 2026 · NCT06108232SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 28, 2026 · NCT05303519Mula sa ClinicalTrials.gov, na-kuha noong Set 30, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.